Amicus Therapeutics Inc (NASDAQ:FOLD)

13.57
Delayed Data
As of Apr 25
 -0.22 / -1.60%
Today’s Change
6.41
Today|||52-Week Range
17.40
-5.70%
Year-to-Date

Today’s Trading

Previous close13.79
Today’s open13.81
Day’s range13.30 - 13.87
Volume1,934,995
Average volume (3 months)2,886,860
Market cap$2.8B
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)-24.16%
Earnings growth (this year)+23.60%
Earnings growth (next 5 years)-57.25%
Revenue growth (last year)+644.86%
P/E ratioNM
Price/Sales59.76
Price/Book7.06

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.01+0.06%
RAREUltragenyx Pharmaceu...-1.12-2.13%
LOXOLoxo Oncology Inc+3.04+2.35%
SUPNSupernus Pharmaceuti...+0.60+1.28%
Data as of 4:00pm ET, 04/25/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$36.9M
Annual profit (last year)-$284.0M
Net profit margin-769.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts